Omnicell
Omnicell is an American healthcare technology company that automates medication management and supports medication adherence and patient engagement.
Last updated October 14, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Omnicell is an American healthcare technology company focused on the management, dispensing, compounding, packaging, and use of medications. Its principal customers include hospitals, health systems, pharmacies, and other healthcare providers. The company combines automated hardware, pharmacy workflow software, analytics, inventory systems, and patient-facing services under the Omnicell and EnlivenHealth brand families. The company was founded in September 1992 as Omnicell Technologies by Randall A. Lipps. The founding idea came from Lipps's observation of nurses struggling to locate medical supplies while he was visiting his newborn daughter in a hospital. With assistance from Stanford graduate students, he developed a prototype intended to automate inventory control and reduce the amount of time clinical staff spent searching for supplies. Omnicell began commercial development of automated supply cabinets in 1993. These systems could record transactions, monitor inventory, track expenses, and support patient billing, turning a manually managed supply process into a controlled, data-generating workflow. Omnicell expanded from supply management into medication automation during the 1990s. In 1996 it developed pharmacy automation systems for dispensing medicines, and in 1999 it acquired Baxter Healthcare's SureMed pharmacy-cabinet line. By the end of that decade, the company had installed more than 14,000 automated dispensing cabinets in over 1,300 healthcare facilities and had reached approximately $50 million in sales. The company filed for an initial public offering in 2001 and changed its name from Omnicell Technologies, Inc. to Omnicell, Inc. that year. Randall A. Lipps became chief executive officer in 2002, succeeding Sheldon D. Asher. During the 2000s and 2010s, Omnicell broadened its portfolio through both internal development and acquisitions. The purchase of BCX Technology in 2003 added wireless handheld barcode-scanning capabilities for tracking pharmaceutical dispensing. The acquisition of MTS Medication Technologies in 2012 expanded the company into medication-adherence packaging, including multiple-dose blister-card systems used by retail pharmacies. Omnicell subsequently added pharmacy and healthcare technology businesses in Europe and North America, including SurgiChem, Mach4 Pharma Systems, Aesynt, Ateb, InPharmics, and the 340B Link business of Pharmaceutical Strategies Group. Aesynt, acquired in 2016, strengthened Omnicell's hospital-pharmacy offering with central pharmacy dispensing robots, intravenous compounding automation, inventory systems, and pharmacy data-intelligence software. Ateb and its Canadian affiliate added patient-care, communication, and medication-synchronization solutions for independent and chain pharmacies. These retail-pharmacy capabilities were later organized into the EnlivenHealth business segment in 2020. EnlivenHealth extended Omnicell's scope beyond physical automation by providing patient engagement and pharmacy communication technologies. Omnicell's overall positioning is centered on medication-use automation and the creation of a connected medication-management ecosystem. In hospitals, its systems are designed to improve medication security, inventory visibility, dispensing efficiency, and pharmacy workflow. In retail and community pharmacy environments, its offerings address adherence packaging, medication synchronization, patient communication, and engagement. The company also uses partnerships to expand implementation and distribution, including a 2015 UK distribution partnership with Avantec and a 2021 collaboration with Guy's and St Thomas' NHS Foundation Trust to develop technology-enabled inventory optimization and intelligence services. The brand is therefore best understood not as a consumer medicine label but as a business-to-business healthcare technology platform. Its products sit at multiple points in the medication lifecycle, from pharmacy inventory and preparation to dispensing, administration, adherence, and patient communication. Omnicell remains an active multinational company headquartered in Fort Worth, Texas, with products marketed under the Omnicell and EnlivenHealth names.
History
Omnicell began in September 1992 as Omnicell Technologies, founded by Randall A. Lipps. The original concept arose from Lipps's experience observing nurses spend time locating medical supplies during a hospital visit involving his newborn daughter. Working with Stanford graduate students, he developed a prototype for automating inventory management tasks that had traditionally been performed manually by clinical staff. Commercial development of automated supply cabinets began in 1993. The cabinets were designed to record transactions, monitor inventory, track expenses, and support patient billing. This gave hospitals a way to improve supply control while producing information about usage and costs. Omnicell entered pharmacy automation in 1996 by developing systems for medication dispensing. In 1999 it acquired Baxter Healthcare's SureMed pharmacy-cabinet line, broadening its product offering. By the end of the 1990s, Omnicell had installed over 14,000 automated dispensing cabinets across more than 1,300 healthcare facilities, while reported sales had reached approximately $50 million. The company filed for an initial public offering in August 2001 at a stated price of $7 per share. In the same year, Omnicell Technologies adopted the name Omnicell, Inc. Sheldon D. Asher was replaced as chief executive by founder Randall A. Lipps in 2002. The company continued to add medication-tracking and pharmacy workflow capabilities. In 2003 it acquired BCX Technology, a maker of wireless handheld barcode scanners used to track pharmaceutical dispensing. This helped connect medication automation with identification and transaction data. Omnicell's expansion accelerated through acquisitions during the 2010s. MTS Medication Technologies, acquired in 2012, added medication-adherence packaging systems and multiple-dose blister cards used by retail pharmacies. In 2014 Omnicell acquired the UK-based SurgiChem business. In 2015 it acquired German robotic dispensing provider Mach4 Pharma Systems and entered a UK distribution partnership with Avantec. In 2016 Omnicell acquired Aesynt for $275 million, adding central pharmacy dispensing robots, IV compounding robots, inventory-management capabilities, and pharmacy data-intelligence software. It also acquired Ateb and Ateb Canada, whose products supported pharmacy-based patient care, patient communication, and medication synchronization for independent and chain pharmacies. In 2017 it acquired InPharmics, a Mississippi-based provider of pharmacy informatics technology and services for hospital pharmacies. In 2020 it acquired the 340B Link business of Pharmaceutical Strategies Group and organized Ateb-related patient-engagement and communication activities into the EnlivenHealth segment. The company's later development emphasized connected healthcare operations rather than standalone dispensing equipment. Omnicell's portfolio came to cover automated dispensing cabinets, central pharmacy robotics, IV compounding, inventory intelligence, pharmacy informatics, adherence packaging, medication synchronization, and patient engagement. In 2021 it partnered with Guy's and St Thomas' NHS Foundation Trust in London to develop inventory optimization and intelligence services. Omnicell is headquartered in Fort Worth, Texas, and its products are marketed under the Omnicell and EnlivenHealth names.
- 2021
Partnership with Guy's and St Thomas' NHS Foundation Trust
[1]The parties worked on technology-enabled inventory optimization and intelligence services.
- 2020
EnlivenHealth segment established
[1]Omnicell organized pharmacy patient-engagement and communication capabilities under the EnlivenHealth name.
- 2017
InPharmics acquired
[1]The transaction added hospital-pharmacy informatics technology and services.
- 2016
Aesynt and Ateb acquired
[1]These acquisitions expanded Omnicell into pharmacy robotics, IV compounding, analytics, patient communication, and medication synchronization.
- 2015
Mach4 acquisition and Avantec partnership
[1]Omnicell acquired Mach4 Pharma Systems and partnered with Avantec to distribute products in the UK.
- 2014
SurgiChem acquired
[1]The acquisition expanded Omnicell's UK operations.
- 2012
MTS Medication Technologies acquired
[1]Omnicell entered a larger role in medication-adherence packaging and retail-pharmacy systems.
- 2003
BCX Technology acquired
[1]The acquisition added wireless handheld barcode scanners for tracking pharmaceutical dispensing.
- 2001
Initial public offering and corporate name change
[1]Omnicell filed for an initial public offering and changed its name from Omnicell Technologies, Inc. to Omnicell, Inc.
- 1999
SureMed product line acquired
[1]Omnicell acquired Baxter Healthcare's SureMed pharmacy-cabinet line.
Products and positioning
Healthcare technology provider specializing in medication management automation, pharmacy workflow optimization, inventory intelligence, medication adherence, and patient engagement.
Hospital medication management · 1993
Automated Dispensing Cabinets
Omnicell's automated cabinets manage access to medicines and healthcare supplies in hospitals and other clinical settings. They are designed to record transactions, monitor inventory, support accountability, and connect dispensing activity with pharmacy and patient-care workflows. The product family developed from the company's original automated supply-cabinet work and became a core part of its hospital technology portfolio.
Pharmacy robotics
Central Pharmacy Automation
Central pharmacy automation includes robotic systems for medication dispensing and inventory management. These systems are intended to standardize repetitive pharmacy operations, improve visibility into stock, and connect preparation and dispensing processes with broader medication-management software.
Sterile medication preparation · 2016
IV Compounding Automation
Omnicell's IV compounding capabilities were added through the Aesynt acquisition. The systems automate specialized preparation tasks for intravenous medications and are positioned as tools for improving consistency, workflow control, and medication-safety processes in hospital pharmacies.
Retail pharmacy technology · 2012
Medication Adherence Packaging
The medication-adherence portfolio includes multiple-dose blister cards and related packaging systems used by retail pharmacies. These products organize a patient's medicines into scheduled doses and support pharmacy programs intended to make routine medication use easier to manage.
Healthcare software · 2016
Pharmacy Informatics and Analytics
Omnicell's informatics and analytics tools provide data related to pharmacy inventory, medication movement, dispensing activity, and operational performance. The capabilities came from both internal development and acquisitions such as Aesynt and InPharmics, and are intended to support evidence-based pharmacy management.
Pharmacy patient engagement · 2020
EnlivenHealth
EnlivenHealth is Omnicell's business segment for pharmacy-based patient engagement, communication, medication synchronization, and related adherence services. It serves independent and chain pharmacies and extends the company's role from back-end automation into ongoing interaction between pharmacies and patients.
Medication identification and tracking · 2003
Wireless Barcode Tracking
Wireless handheld barcode-scanning technology, added through the BCX Technology acquisition, supports the identification and tracking of pharmaceutical dispensing transactions. It complements automated cabinets and pharmacy systems by linking medication movement to electronic records.
Brand decisions
2021
Develop inventory intelligence with Guy's and St Thomas' NHS Foundation TrustStrategyBackground
Healthcare providers were seeking more data-driven ways to manage medication and medical inventory.
Action taken
Omnicell partnered with Guy's and St Thomas' NHS Foundation Trust to develop technology-enabled inventory optimization and intelligence services.
Aftermath
The partnership reflected Omnicell's strategy of combining automation with operational data and analytics.
2020
Create the EnlivenHealth business segmentStrategyBackground
Omnicell had accumulated pharmacy patient-engagement and communication capabilities through the Ateb acquisition.
Action taken
The company organized those activities under the EnlivenHealth business segment.
Aftermath
The structure gave Omnicell a distinct platform for retail-pharmacy engagement, medication synchronization, and adherence-related services.
2016
Acquire Aesynt to expand pharmacy automationM&ABackground
Omnicell sought to broaden its hospital-pharmacy portfolio beyond automated cabinets and dispensing systems.
Action taken
The company acquired Aesynt, adding central pharmacy dispensing robotics, IV compounding robotics, inventory-management capabilities, and pharmacy data analytics.
Aftermath
The transaction strengthened Omnicell's position across hospital pharmacy automation and connected medication-management workflows.
Acquisition price. $275 million (2016)
2016
Acquire Ateb to enter broader pharmacy patient engagementM&ABackground
Omnicell wanted to extend its offering into retail-pharmacy patient care and medication adherence.
Action taken
Omnicell acquired Ateb and its Canadian affiliate, adding patient communication, patient-care, and medication-synchronization solutions.
Aftermath
The acquired capabilities later became part of the EnlivenHealth business segment established in 2020.
Recent events
- 2021
Omnicell partners with Guy's and St Thomas' NHS Foundation Trust[1]
Other
The partnership aimed to develop technology-enabled inventory optimization and intelligence services for healthcare operations.
- 2020
Omnicell acquires 340B Link business[1]
M&A
Omnicell acquired the 340B Link business of Pharmaceutical Strategies Group, adding capabilities associated with the 340B pharmacy program.
- 2020
Omnicell forms EnlivenHealth business segment[1]
Leadership change
Ateb-related patient-engagement and pharmacy communication activities were organized under the EnlivenHealth business segment.
- 2017
Omnicell acquires InPharmics[1]
M&A
The acquisition expanded Omnicell's pharmacy informatics capabilities for hospital pharmacies.
- 2016
Omnicell acquires Aesynt[1]
M&A
The acquisition brought central pharmacy dispensing robotics, IV compounding automation, and pharmacy data analytics into Omnicell's portfolio.
- 2016
Omnicell acquires Ateb and Ateb Canada[1]
M&A
The transaction added pharmacy-based patient-care, communication, and medication-synchronization technologies.
- 2015
Omnicell acquires Mach4 Pharma Systems[1]
M&A
The acquisition added a Germany-based provider of robotic dispensing systems.
- 2015
Omnicell partners with Avantec for UK distribution[1]
Other
The partnership supported distribution of Omnicell products in the United Kingdom.
- 2014
Omnicell acquires SurgiChem[1]
M&A
Omnicell acquired the UK-based SurgiChem business, extending its international healthcare and pharmacy technology operations.
- 2012
Omnicell acquires MTS Medication Technologies[1]
M&A
The acquisition expanded Omnicell's medication-adherence packaging capabilities and strengthened its presence in retail pharmacy technology.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/omnicell · Editorial policy · How profiles are compiled